| 000 | 01851 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515200955.0 | ||
| 264 | 0 | _c20100614 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1931-8448 | ||
| 024 | 7 |
_a10.1089/mdr.2009.0107 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSturm, Patrick D J | |
| 245 | 0 | 0 |
_aPrevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. _h[electronic resource] |
| 260 |
_bMicrobial drug resistance (Larchmont, N.Y.) _cMar 2010 |
||
| 300 |
_a55-60 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAcademic Medical Centers |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aDNA, Bacterial _xanalysis |
| 650 | 0 | 4 |
_aEnterobacteriaceae _xdrug effects |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aGenes, Bacterial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKlebsiella oxytoca _xdrug effects |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 |
_abeta-Lactam Resistance _xgenetics |
| 650 | 0 | 4 |
_abeta-Lactamases _xgenetics |
| 650 | 0 | 4 |
_abeta-Lactams _xpharmacology |
| 700 | 1 | _aBochum, Els T M | |
| 700 | 1 | _avan Mook-Vermulst, Sacha V M | |
| 700 | 1 | _aHandgraaf, Cindy | |
| 700 | 1 | _aKlaassen, Twan | |
| 700 | 1 | _aMelchers, Willem J G | |
| 773 | 0 |
_tMicrobial drug resistance (Larchmont, N.Y.) _gvol. 16 _gno. 1 _gp. 55-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/mdr.2009.0107 _zAvailable from publisher's website |
| 999 |
_c19383992 _d19383992 |
||